 MIAMI, May 17, 2022 GLOBE NEWSWIRE -- Veru Inc. NASDAQ: VERU, a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will present at the H.C. Wainwright Global Investment Conference. The presentation will be available through the Conference on Tuesday, May 24th at 11:30 AM 12:00 PM Eastern Daylight Time. 